x

Search for a clinical trial

* (*) mandatory field

GeDDiS : A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first line treatment in previously untreated advanced unresectable or metastatic soft tissue sarcomas - GB

  • Type of clinical trial : Protocol clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : University college london
  • Website
    • Phase : III
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • The London Sarcoma Service
  • UCLH NHS Foundation Trust - University College Hospital
  • 235 Euston Road
  • LONDON NW1 2BU
  • UNITED KINGDOM
  • More information
  • Phone  : 44 (0)203 447 4821
  • Fax  : 44 (0)203 447 9536
  • Website
  • Sponsor of clinical trial

  • UNIVERSITY COLLEGE LONDON
  • University College London (UCL) and University College London Hospitals NHS Trust (UCLH)
  • Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
  • Rosenheim Wing, Ground floor, 25 Grafton Way
  • LONDON WC1E 5DB
  • UNITED KINGDOM
  • More information
  • Phone  : -
  • Fax  : -
  • Website
  • Contact secretary  :
Last update: June 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.